Pharma · Private company

Astellas Pharma Global Development, Inc.

Track this companyFree. Adds Astellas Pharma Global Development, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2525 recruiting or active

Pipeline programs74From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline74

5-fluorouracil (5-FU)Phase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
5-FUPhase 3 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
ASP2138Phase 3 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CapecitabinePhase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
CapecitabinePhase 3 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CisplatinPhase 3 · Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
Conventional RadiotherapyPhase 3 · Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 3 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
Enfortumab vedotinPhase 3 · Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
fluorouracilPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
fluorouracilPhase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
FluorouracilPhase 3 · Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
folinic acidPhase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
Folinic acidPhase 3 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Folinic acid (leucovorin or local equivalent)Phase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
Hypofractionated RadiotherapyPhase 3 · Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
IrinotecanPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
LeucovorinPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
liposomal irinotecanPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Mitomycin CPhase 3 · Urothelial CancerClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 3 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
SetidegrasibPhase 3 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
SetidegrasibPhase 3 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
zolbetuximabPhase 3 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerClinicalTrials.gov · fetched Nov 12, 2026
5-fluorouracilPhase 2 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
abiraterone acetatePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Adrenocorticotropic hormonePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
ASP2767Phase 2 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
ASP2998Phase 2 · Locally Advanced or Metastatic Malignant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
ASP388BPhase 2 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
ASP546CPhase 2 · Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
ASP5541Phase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
AzacitidinePhase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Locally Advanced or Metastatic Malignant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Enfortumab VedotinPhase 2 · Muscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
Enfortumab VedotinPhase 2 · Locally Advanced or Metastatic Malignant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
enzalutamidePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
gemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
GilteritinibPhase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
Leuprolide acetatePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
nab-paclitaxelPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 2 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · Locally Advanced or Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · Muscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · Locally Advanced or Metastatic Malignant Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PrednisolonePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
prednisonePhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Prophylactic Regimen APhase 2 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
Prophylactic Regimen BPhase 2 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
Sham ASP2767Phase 2 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
VenetoclaxPhase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
zolbetuximabPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
5-FUPhase 1 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Androgen receptor signaling inhibitor (ARSI)Phase 1 · Hormone-refractory Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
ASP2138Phase 1 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 1 · Hormone-refractory Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
FluorouracilPhase 1 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
GemcitabinePhase 1 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
gilteritinibPhase 1 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
IrinotecanPhase 1 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
LeucovorinPhase 1 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
LeucovorinPhase 1 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
mFOLFIRINOXPhase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
OxaliplatinPhase 1 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
RamucirumabPhase 1 · Gastric AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
VIR-5500Phase 1 · Hormone-refractory Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
zolbetuximabPhase 1 · Metastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Avacincaptad pegol (ACP)Geographic AtrophyClinicalTrials.gov · fetched Nov 12, 2026
No InterventionStargardt DiseaseClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve DamagePHASE1_PHASE2 · RECRUITING · started Oct 7, 2026ClinicalTrials.gov NCT07770685 · fetched Nov 12, 2026
A Natural History Study of Angelman SyndromeRECRUITING · started Sep 9, 2026ClinicalTrials.gov NCT07417137 · fetched Nov 12, 2026
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsPHASE1_PHASE2 · RECRUITING · started Sep 2, 2026ClinicalTrials.gov NCT07730021 · fetched Nov 12, 2026
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationPHASE3 · RECRUITING · started Aug 19, 2026ClinicalTrials.gov NCT07566052 · fetched Nov 12, 2026
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerPHASE3 · RECRUITING · started Jul 28, 2026ClinicalTrials.gov NCT07673887 · fetched Nov 12, 2026
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)PHASE3 · RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07566156 · fetched Nov 12, 2026
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsPHASE1_PHASE2 · RECRUITING · started May 4, 2026ClinicalTrials.gov NCT07488676 · fetched Nov 12, 2026
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderPHASE2 · RECRUITING · started Mar 12, 2026ClinicalTrials.gov NCT07475806 · fetched Nov 12, 2026
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsRECRUITING · started Feb 20, 2026ClinicalTrials.gov NCT07425574 · fetched Nov 12, 2026
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerPHASE3 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07409272 · fetched Nov 12, 2026
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsPHASE1_PHASE2 · RECRUITING · started Feb 5, 2026ClinicalTrials.gov NCT07287995 · fetched Nov 12, 2026
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerPHASE1 · RECRUITING · started Oct 16, 2025ClinicalTrials.gov NCT07024615 · fetched Nov 12, 2026
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 24, 2025ClinicalTrials.gov NCT06396091 · fetched Nov 12, 2026
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)PHASE1 · RECRUITING · started Sep 22, 2025ClinicalTrials.gov NCT07140016 · fetched Nov 12, 2026
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerPHASE2 · RECRUITING · started Aug 19, 2025ClinicalTrials.gov NCT07005154 · fetched Nov 12, 2026
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerPHASE3 · RECRUITING · started May 22, 2025ClinicalTrials.gov NCT06901531 · fetched Nov 12, 2026
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic AtrophyACTIVE_NOT_RECRUITING · started Jan 22, 2025ClinicalTrials.gov NCT06779773 · fetched Nov 12, 2026
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerPHASE1 · RECRUITING · started Aug 10, 2023ClinicalTrials.gov NCT05997615 · fetched Nov 12, 2026
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 31, 2023ClinicalTrials.gov NCT05520567 · fetched Nov 12, 2026
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerPHASE1 · RECRUITING · started Jun 7, 2022ClinicalTrials.gov NCT05365581 · fetched Nov 12, 2026
A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 10, 2020ClinicalTrials.gov NCT04225117 · fetched Nov 12, 2026
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 15, 2019ClinicalTrials.gov NCT03816163 · fetched Nov 12, 2026
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 28, 2018ClinicalTrials.gov NCT03653507 · fetched Nov 12, 2026
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 21, 2018ClinicalTrials.gov NCT03504397 · fetched Nov 12, 2026
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 22, 2016ClinicalTrials.gov NCT02960022 · fetched Nov 12, 2026